De novo T cell responses generated via immuno-ablative therapy provide protective antitumor immunity to poorly immunogenic tumors

Ashley R. Hoover; Saghar Kaabinejadian; William H. Hildebrand; Wei R. Chen

doi:10.1117/12.2611804

7 March 2022 De novo T cell responses generated via immuno-ablative therapy provide protective antitumor immunity to poorly immunogenic tumors

Ashley R. Hoover, Saghar Kaabinejadian, William H. Hildebrand, Wei R. Chen

Author Affiliations +

Proceedings Volume PC11961, Biophotonics and Immune Responses XVII; PC1196103 (2022) https://doi.org/10.1117/12.2611804
Event: SPIE BiOS, 2022, San Francisco, California, United States

There is no online version at this time. The PDF is only available to people who have bought the paper or have a subscription.

Conference Presentation

Citation Download Citation

Ashley R. Hoover, Saghar Kaabinejadian, William H. Hildebrand, and Wei R. Chen "De novo T cell responses generated via immuno-ablative therapy provide protective antitumor immunity to poorly immunogenic tumors", Proc. SPIE PC11961, Biophotonics and Immune Responses XVII, PC1196103 (7 March 2022); https://doi.org/10.1117/12.2611804

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available